Toll‐Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Toll‐like receptors (TLRs) are the important mediators of inflammatory pathways in the gut which play a major role in mediating the immune responses towards a wide variety of pathogen‐derived ligands and link adaptive immunity with the innate immunity. Numerous studies in different populations across the continents have reported on the significant roles of TLR gene polymorphisms in modulating the risk of colorectal cancer (CRC). CRC is one of the major malignancies affecting the worldwide population and is currently ranking the third most common cancer in the world. In this review, we have attempted to discuss the structure, functions, and signaling of TLRs in comprehensive detail together with the role played by various TLR gene SNPs in CRC susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pollutant-driven alterations in TLR recognition of pathogens may contribute to the increased susceptibility and severity of viral infections, as well as the pathogenesis of airway diseases like asthma.”
From Is Pollution the Primary Driver of Infectious Syndemics? (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TLRs can be activated by pathogen-associated molecular patterns (PAMPs) (e.g., bacteria, viruses, or fungi) and DAMPs (e.g., protein aggregates, ATP, mtDNA).277”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [277]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 6×
“Majority of the immune response elicited by the TLRs is due to the highly specific ectodomain containing a germ line encoded and highly conserved LRR region [18, 31, 53].”
BackgroundInfluentialThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 6×
“Most of the PRRs after getting activated by the molecular patterns from the pathogens cause the upregulation of the inflammatory response gene especially proinflammatory cytokines and type I interferons [18, 35, 42].”
BackgroundInfluentialPattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895 · cited 14×
“TRIF-dependent pathway It is utilized by TLR3 and TLR4 to trigger the enhanced expression of interferon type-1 genes.”
BackgroundInfluentialAkira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · cited 1×
“For TLRs, various adaptor molecules have been identified which get recruited to the CTD domain of the activated and/or dimerized receptor to pass the signal downstream of the cell [31, 72, 73].”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728 · cited 1×
“CRC initiation and progression follow a multigene and multistage genetic instability model called the Vogelstein model of carcinogenesis [12].”
MethodA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
BackgroundTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · cited 1×
“Some of the TLRs are highly specific in recognizing and binding to some particular ligands, like TLR2 for lipoproteins, lipotechoic acid (LTA), peptidoglycans (PG), zymosan and porin [65, 66], TLR3 for dsRNA derived from viruses [67], TLR4 for gram-negative bacteria-derived lipopolysaccharides (LPS) and plant-derived…”
Background
Research works printed but not linked: 1
- Ferlay J. Ervik M. Lam F. Cancer today (powered by GLOBOCAN 2018) IARC Cancer Base number 2018 p. 15 June 2021, https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“, protein aggregates, ATP, mtDNA).(277) TLR activation leads to receptor dimerization and the recruitment of adapter proteins, such as Toll/interleukin 1 receptor (TIR) domain-containing adapter interferon-β (TRIF) and myeloid differentiation primaryresponse protein 88 (MyD88)(276) (Fig.”
BackgroundFornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
“Meanwhile, the CTD participates in interactions with various signal transduction adaptors, initiating downstream signaling through its toll-IL-1 receptor (TIR) homologous domain (219).”
BackgroundMukherjee, S., Patra, R., Behzadi, P., Masotti, A., Paolini, A., & Sarshar, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244345 · Cited by 166
Kaur, H., & Ali, S. A. (2022) · Food & Function · doi:10.1039/d2fo00911k · Cited by 137
The role of p53 in anti-tumor immunity and response to immunotherapy
Carlsen, L., Zhang, S., Tian, X., De La Cruz, A., George, A., Arnoff, T. E., & El-Deiry, W. S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1148389 · Cited by 100
“TLR3, 5, 7, 8, and 9 are primarily involved in the innate immune response and trigger type I interferon (IFN) synthesis through IFN regulatory factors (IRFs) (Sameer and Nissar, 2021).”
Background
Metadata
- Authors
- Sameer, A. S., & Nissar, S.
- Affiliations
- Government Medical College (IN)
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2021-01
- Volume
- 2021
- Issue
- 1
- Pages
- 1157023-1157023
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC8452412
- OpenAlex
- W3200104592
- Cited by
- 323
- References
- 128
- Citations by year
- 2026: 41 · 2025: 90 · 2024: 101 · 2023: 62 · 2022: 29
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Toll-like receptors, colorectal cancer, genetic polymorphism, single nucleotide polymorphisms, Toll-like receptor signaling, innate immunity, intestinal inflammation, cancer susceptibility
- MeSH terms
- Humans, Ligands, Polymorphism, Genetic, Colorectal Neoplasms, Signal Transduction, Genetic Predisposition to Disease, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



